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CRISPR-based gene drives offer promising means to reduce the burden of pests and vector-
borne diseases. These techniques consist of releasing genetically modified organisms car-
rying CRISPR-Cas nucleases designed to bias their inheritance and rapidly propagate desired
modifications. Gene drives can be intended to reduce reproductive capacity of harmful
insects or spread anti-pathogen effectors through wild populations, even when these confer
fitness disadvantages. Technologies capable of halting the spread of gene drives may prove
highly valuable in controlling, counteracting, and even reverting their effect on individual
organisms as well as entire populations. Here we show engineering and testing of a genetic
approach, based on the germline expression of a phage-derived anti-CRISPR protein
(AcrIIA4), able to inactivate CRISPR-based gene drives and restore their inheritance to
Mendelian rates in the malaria vector Anopheles gambiae. Modeling predictions and cage
testing show that a single release of male mosquitoes carrying the AcrIIA4 protein can block
the spread of a highly effective suppressive gene drive preventing population collapse of
caged malaria mosquitoes.
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The management of vector and pest populations usingnuclease-based gene drives is becoming a realistic possi-bility, particularly after the recent proof-of-principle
demonstrations of genetic control technologies based on the
broadly applicable CRISPR–Cas nucleases1. These technologies
rely on the release of genetically engineered individuals that can
rapidly propagate genetic constructs through wild populations
together with the linked genetic modifications (e.g., knockout of
sex determination2 or fertility genes3) or the introduction of
genetic cargos (e.g., pathogen-killing molecules designed to block
the development of parasites within the vector4). Several gene
drive systems have been proposed and a few potential candidate
strains have already been developed in the laboratory for the
control of several organisms, including invasive rodents5, agri-
cultural pests6,7 and disease vectors2–4,8,9. Access to effective ways
to counteract the spread of gene drive elements is highly valued
for risk mitigation and management alongside the implementa-
tion of these strategies: e.g., as a possible intervention in the case
of unintended releases. This is particularly relevant for self-
sustaining strategies showing high potential of spread, especially
when these are set to control non-confined populations dispersed
in large areas across multiple countries.
The first example of gene drive reversal systems was inspired
by naturally occurring resistance to gene drives in the form of
cleavage-refractory modification of the DNA sequence targeted
by the driving endonuclease. Resistant alleles can pre-exist in the
population as polymorphisms, or be generated de novo through
non-homologous end-joining (NHEJ) repair of endonuclease-
induced cleavage10–13. Anti-drive individuals could be genetically
engineered to carry similar “drive-refractory alleles” and used to
rescue the target population8,10. However, refractory alleles rely
on a selective advantage conferred by the higher fitness compared
to the drive, and therefore will have little effect on gene drives
with low fitness cost (e.g., population-replacement drives)14. In
addition, there are cases where tight functional constraints at the
gene drive target sequence may hinder the development of this
type of reversal approach, such as for the dsx-targeting gene drive
that we recently developed in the malaria vector Anopheles
gambiae2. Alternative reversal strategies involve the use of
CRISPR components to cleave and replace DNA sequences spe-
cific to the gene drive construct with15,16 or without17–19 the use
of an additional Cas9 expression cassette. Recently, guide RNA-
only systems developed in Drosophila showed capacity to inac-
tivate or replace gene drives in caged populations19. Although
these strategies may offer the option to replace the drive with one
or few “refractory alleles” or even restore the wild-type popula-
tion, there are several complications attributable to the DNA-
cleaving nature of the reversal that remain to be addressed, such
as the formation and selection of resistant alleles and/or genomic
rearrangement at the drive locus targeted by the reversal nuclease.
In this work, we describe the development and validation of a
widely applicable genetic tool to counteract CRISPR-based gene
drives by expressing a Cas9-inhibiting protein in a spatial and
temporal manner coinciding with the gene drive activity, thereby
circumventing problems related to additional cleavage of genomic
sequences. We generated an A. gambiae transgenic line expres-
sing the AcrIIA4 protein from the Listeria monocytogenes
prophage20–23, and assessed its ability to both inhibit super-
Mendelian inheritance of different driving constructs and prevent
gene drive-mediated suppression of caged malaria mosquito
populations.
Results
Generation of the vasa:A4 (anti-drive) line expressing the
AcrIIA4 protein in the mosquito germline. CRISPR-based
homing gene drive constructs exploit the germline-specific
action of the ribonucleoprotein complex (e.g., Cas9–gRNA),
which is designed to recognise and cleave a DNA sequence
homologous to the one where the drive-encoding construct is
inserted. Double-strand breaks generated in premeiotic cells are
preferentially repaired using the uncleaved homologous chro-
mosome as a template through the homology-directed repair
process, thus resulting in the drive-containing DNA strand
being copied into the wild-type chromosome. As a consequence
of germline maturation and subsequent fertilisation of a wild-
type individual, the gene drive element is transmitted to the
majority of the progeny, resembling a homozygous trait, and
therefore increases its frequency in the population over gen-
erations. Aiming to inhibit this process, we genetically engi-
neered an anti-drive transgenic line where the nuclear
localisation signal (NLS)-tagged AcrIIA4 protein is expressed
under the vasa promoter, transcriptionally active in the germ-
line of both A. gambiae male and females24. As confirmed
in vitro, fusion to various NLS tags does not perturb inhibition
of Cas9 activity by AcrIIA4 (Supplementary Fig. 1). The anti-
drive construct was inserted via embryo microinjection in a pre-
existing docking line25. The identification of successful genomic
integrations was based on the expected combination of fluor-
escent marker expression: the eGFP linked to anti-drive con-
struct, and the eCFP already present at the docking site (Fig. 1).
The progeny derived from a single eGFP (and eCFP) positive
individual was used to establish the anti-drive transgenic line
(identified as vasa:A4) after molecular confirmation of correct
insertion of the construct (Supplementary Fig. 2a, b).
Germline expression of AcrIIA4 imposes Mendelian trans-
mission of gene drive constructs. To test the AcrIIA4 inhibitory
activity of gene drive homing in the mosquito germline, we
crossed female mosquitoes hemizygous for the anti-drive con-
struct (vasa:A4+/−) to the three most effective A. gambiae gene
drive lines currently available. The zpg:dsxF line (previously
identified as dsxFCRISPRh2) carries a driving construct, where the
Cas9 from Streptococcus pyogenes (herein identified as Cas9) is
expressed under the zpg regulatory elements, inserted within the
sex-determining gene AgdsxF (AGAP004050-RB) to disrupt the
production of the female splicing variant. Functional constraint of
the targeted sequence allowed the driving construct to rapidly
spread and eliminate caged mosquito populations by progressively
reducing the reproductive capacity of females2. The zpg:7280 and
nos:7280 lines (previously named zpgCRISPRh and nosCRISPRh 26)
showed a dramatic improvement of the first generation of sup-
pressive gene drives3 by tuning the temporal expression of the
Cas9 through the use of the zpg and nos promoters. In both lines,
homing of the CRISPR cassette disrupts the haplosufficient female
fertility gene AGAP00728026. Male and female mosquitoes carry-
ing one copy of both drive and anti-drive constructs (zpg:dsxF+/−;
vasa:A4+/−, zpg:7280+/−;vasa:A4+/− and nos:7280+/−;
vasa:A4+/−) were crossed to wild-type individuals to assess ferti-
lity and analyse transmission frequencies of drive (D) and anti-
drive (A) alleles to their progenies by screening for expression of
the linked RFP (drive) and GFP (anti-drive) fluorescent markers.
Individuals carrying only the drive or the anti-drive construct
were also crossed to the wild-type counterpart as a control
(Fig. 2a). Inheritance of the anti-drive allele from vasa:A4+/−
individuals was close to the expected Mendelian rates (average of
56.5% GFP positive from females and 57% from males), while all
drive+/− individuals transmitted the drive allele to most of the
progeny as consequence of homing (averages ranging from 88.5%
up to 100% of RFP positives found in the progeny). Notably,
individuals carrying both drive and anti-drive transgenes showed a
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striking reduction of inheritance of the drive allele down to
Mendelian rates (averaging from 46.3 to 51.1% of RFP positives),
in line with complete blockage of Cas9–gRNA cleavage activity
and consequent inhibition of germline homing (Fig. 2b).
Fitness analysis of the vasa:A4 anti-drive line. Fertility assays did
not show any substantial reduction in progeny outputs from indi-
viduals carrying one copy of the anti-drive construct (D+/−;A+/− or
A+/−) compared to the respective gene drive controls (D+/−),
giving a minimum normalised value (NV) of larvae produced per
females of 0.77 from nos:7280+/−;vasa:A4+/− males (Welch’s
t test P= 0.2544) and zpg:7280+/−;vasa:A4+/− females (Welch’s
t test P= 0.0732). On the other hand, a higher number of larvae
(NV= 1.57) was obtained from zpg:dsxF+/−;vasa:A4+/− females
compared to zpg:dsxF+/− females. Although this difference was not
statistically significant when comparing independent oviposition
counts from each cross (Welch’s t test P= 0.1035), the difference in
overall number of larvae hatched was significant for all three crosses
cited above (Fisher’s exact test). Notwithstanding that this type of
phenotype assays may be affected by interindividual or batch
variability, previous studies showed that parental deposition of Cas9
in the embryo can cause reduction of fertility in D+/− females by
generating embryonic mosaicisms for somatic null mutations at the
targeted site, which are produced via NHEJ repairs10,26. These
studies also indicated that the severity of this reduction varies
among the different genes targeted and according to the promoter
used to express the Cas9 protein, reflecting high levels of maternal
depositions when the Cas9 expression is driven by the vasa pro-
moter, compared to other regulatory sequences10,26,27. Consistent
with these findings, maternally deposited AcrIIA4 from the vasa
promoter may likely buffer somatic nuclease activity in D+/−;A+/−
embryos and therefore mitigate the impact of null mosaicisms on
the fertility of the developed individuals, as evidenced by the
increased zpg:dsxF+/−;vasa:A4+/− female fertility compared to zpg:
dsxF+/− females (Supplementary Fig. 3a).
Further phenotypic characterisation of anti-drive individuals
showed a moderate reduction in larval output (NV= 0.79,
Welch’s t test P= 0.1398) from males carrying two copies of
the anti-drive construct (A+/+) compared to the wild-type
control tested in parallel. A similar reduction was also seen in
A+/− females (NV larvae per female= 0.79, Welch’s t test P=
0.0277); however, this was not reflected in A+/+ females that gave
an average number of larvae comparable to wild-type (NV= 1.07,
Welch’s t test P= 0.4168), indicating that this fertility impair-
ments may not be directly caused by a double dose of AcrIIA4 in
A+/+ individuals (Supplementary Fig. 3b, c). Furthermore,
fertility assays from trans-hemizygous individuals, carrying one
copy of the anti-drive construct and a marker construct inserted
at the corresponding homologous locus (vasa:A4+/mars+) also
showed similar reductions in larvae outputs compared to the
wild-type control (NV= 0.67 and Welch’s t test P= 0.0147 from
females, NV= 0.84 and Welch’s t test P= 0.1446 from males),
indicating a moderate fitness cost likely associated with the locus
of insertion (Supplementary Fig. 3c). The fraction of mated
females recorded in these experiments also showed a possible
impairment in mating competence that appeared more pro-
nounced in A+/+ males, able to fertilise only 60% of the wild-type
females tested compared to the 89% found in wild-type male
crosses (Fisher’s exact test P= 0.0469). A+/− males were instead
able to fertilise 80% of the females (Fisher’s exact test P= 0.4924).
Although not statistically significant, anti-drive females crossed to
wild-type males showed a reduction in mating with 70% of A+/+
and 81% of A+/− females able to mate in these settings
(Supplementary Table 1).
Single release of anti-drive males prevents elimination of caged
mosquito populations by the suppressing CRISPR–Cas9 gene
drive zpg:dsxF. Fitness values and transmission rates of the
respective alleles were used to generate deterministic and sto-
chastic models to simulate drive and anti-drive genotype
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Fig. 1 Schematic representation of gene drive and anti-drive constructs. Gene drive and anti-drive constructs respectively as inserted in the genome of
the gene drive lines previously generated (zpg:dsxF2; zpg:7280 and nos:7280, ref. 26) and the newly generated anti-drive (vasa:A4) line. Specifically, the
gene drive constructs tested in this work are inserted at target sites within the AGAP007280 or AgdsxF (AGAP004050-RB) gene-coding sequences and
contain: the Streptococcus pyogenes Cas9 nuclease (Cas9), under the transcriptional control of the male and female germline-specific promoters zpg or nos;
the gRNA, targeting the respective insertion site, transcribed by the RNA polymerase III responsive promoter (U6), and the DsRed fluorescent protein
under the 3xP3 promoter (3xP3:DsRed) for the identification of larvae carrying the drive. The anti-drive construct carries the Listeria monocytogenes anti-
CRISPR protein (AcrIIA4) expressed under the vasa male and female germline-specific promoter with the N-terminus addition of a nuclear localisation
signal (NLS) and the eGFP fluorescent protein under the 3xP3 promoter (3xP3:eGFP) used for the screening of anti-drive positive larvae. The construct was
inserted in a pre-existing docking line carrying the 3xP3:eCFP marker25. As a result the AcrIIA4 protein is expected to interact and inhibit the Cas9–gRNA
complex, when co-expressed in the mosquito germline cells.
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frequencies (over discrete generations) after a single release of
vasa:A4 males into a defined population, where individuals car-
rying the zpg:dsxF gene drive (previously developed by Kyrou
et al.2) were introduced. We tested our model predictions by
releasing 20% of vasa:A4 males, after fluorescence microscope-
based enrichment for homozygotes (Supplementary Fig. 2c, d),
into a population of 600 mosquitoes in total, including 50%
heterozygous zpg:dsxF (males and females) and 30% wild-type
individuals. Two experimental replicates were performed in
parallel with two control cages, where 300 heterozygotes for the
zpg:dsxF drive were added to 300 wild-type individuals. Inheri-
tance of drive and/or anti-drive constructs and total egg output
was measured at each generation from the four cages. As
expected, the frequency of zpg:dsxF genotypes increased rapidly
in all cages, leading to elimination of both control populations
after the 6th and 11th generation, as a consequence of the pro-
gressive reduction of egg output. Consistent with model predic-
tions, after an initial increase, the zpg:dsxF spread was halted in
the cages where vasa:A4 males were released, maintaining fre-
quencies between 98.1 and 76.6% after generation 3, and an
average of RFP positive individuals of 87.3% ± 0.05 SD from G3
to G16. Despite not having an inbuilt homing machinery like the
zpg:dsxF drive, the frequency of vasa:A4 carrying individuals also
increased gradually from the ~10% at G1 up to a maximum of
68.1% (Fig. 3a). As also shown by the model simulation, the
gradual increment of anti-drive frequency is determined by the
higher overall fitness linked to the vasa:A4 alleles compared to
the drive (Supplementary Table 2). On the other hand, the egg
output of the two experimental cages was maintained above one-
fifth of the generation after release, with values (relative to G1) of
0.27 and 0.43 at generation 16, when the last measurement was
performed (Fig. 3b). To determine the contribution of nuclease-
resistant alleles over generations, we performed amplicon
sequencing of pooled samples collected at generations 1, 5, 10
(from experimental and control cages) and 15 (for experi-
mental cages). In line with modelling prediction, a progressive
accumulation of mutations at the dsx-target site was observed in
the control cages, reaching a total frequency of 0.047 and 0.062
(among non-drive alleles) in the generations prior to population
collapse. On the contrary, mutations measured from the cages
containing vasa:A4 carrying mosquitoes remained at low levels
and gradually decreased reaching minimum total frequency at
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Fig. 2 Germline expression of anti-CRISPR protein AcrIIA4 causes complete inhibition of gene drive homing. a Schematic representation of gene drive
homing in the germline of individuals carrying one copy of the drive allele (D+/−): Cas9–gRNA-directed cleavage of the insertion site on the homologous
wild-type chromosome is repaired via homology-directed repair (HDR), using the drive-carrying chromosome as template, resulting in the D allele being
copied (the new drivecopy is indicated as dashed magenta rectangle) and transmitted to most of the progeny (left). Illustration of gene drive homing
inhibition in individual carrying one drive and one anti-drive copy (D+/−;A+/−) as consequence of AcrIIA4-directed Cas9–gRNA blockage, resulting in
Mendelian inheritance of the D allele (middle). Mendelian inheritance of the anti-drive from A+/− individuals (right). b Scatter plots showing the
percentage of larvae carrying the gene drive (RFP positive) and/or the anti-drive (GFP positive) constructs from wild-type mosquitoes crossed to
transgenic females or males carrying: only the gene drive construct, confirming high transmission rates (up to 100%) of the D allele from each of the
transgenic lines tested (left); both gene drive and anti-drive constructs, showing Mendelian inheritance of both D and A alleles (middle); only the anti-drive
construct, showing expected Mendelian rates of the A allele (right). Vertical dashed lines indicate the 50%Mendelian inheritance. Error bars indicate mean
percentage values and standard error of the mean of transmission rates from all biological samples assessed for each cross. A minimum of seven
biologically independent samples (ovipositing females) were examined over two independent experiments for each cross, with the exception of zpg:dsxF
crosses, which were examined only once. The respective raw data are provided in the Source data file.
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G15 (0.013 and 0.019; Supplementary Fig. 4a). This result is
consistent with no significant end-joining resistance being gen-
erated from mosquitoes carrying both the drive and anti-drive
constructs (Supplementary Fig. 4b). Although not accounting for
spatial dispersal, our models show a long-term equilibrium
between drive, anti-drive and wild-type alleles (Supplementary
Fig. 5) that is primarily, although not exclusively, dependent on
their relative fitness (Supplementary Fig. 6), as described pre-
viously for other reversal strategies28–30. Allele dynamics over an
extended number of generations shows that a single release of
vasa:A4 anti-drive males can sensibly constrain the gene drive
spread, preventing it from reaching high frequencies and drastic
reproductive load according to the drive/anti-drive relative fre-
quency at release, even when the fitness of females heterozygous
for the drive is considered equal to wild-type, thereby facilitating
the spread of the drive (Supplementary Fig. 6).
Discussion
In this work, we demonstrate that a genetically encoded anti-
CRISPR protein can be highly effective in inhibiting potent
CRISPR-based gene drives engineered to suppress malaria mos-
quitoes by restoring their inheritance to Mendelian rates. Our
experiments show that a single low frequency release of males
carrying the anti-CRISPR construct is highly effective in pre-
venting population suppression, despite a reduced fitness asso-
ciated with the anti-drive.
We successfully tested wide applicability of the AcrIIA4-
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Fig. 3 A single release of AcrIIA4 anti-drive males constrains gene drive spread preventing population suppression in caged mosquitoes. Two cages
were initiated with a starting population of 600 A. gambiae mosquitoes of which 150 males and 150 females heterozygous for the zpg:dsxF driving allele
(initial drive allele frequency of 25%), 120 homozygous-enriched males for the vasa:A4 allele (initial anti-drive allele frequency of 20%) and 180 wild-type of
which 30 males and 150 females to maintain equal sex ratio (left). In parallel, two control cages were established by releasing the same proportion of drive
alleles (150 zpg:dsxF+/− males and 150 zpg:dsxF+/− females) and 300 wild-type mosquitoes (150 males and 150 females). a The frequency of RFP positive
drive (D+, dark purple solid lines), GFP positive anti-drive (A+, dark green solid lines) and non-transgenic individuals (NT, black solid lines) was recorded for
each generation by screening larvae for the expression of the respective fluorescent markers. b Absolute number of eggs produced each generation
(dark grey solid lines). Genotype frequencies (D+, A+ and NT) and egg output (EO) values were overlapped to the respective deterministic (dotted lines)
and stochastic (light-coloured lines) model simulation based on the parameters provided in Supplementary Table 2. The respective raw data are provided
in the Source data file.
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previously engineered for population suppression, and achieved
proof-of-concept of propulation rescue in caged insects.
Here, gene drive inhibition is achieved via protein–protein
interaction, rather than DNA cleavage of drive-specific sequences,
bypassing potential unintended effects of genome editing altera-
tions caused by alternative Cas9–gRNA or gRNA-only reversal
strategies15,17–19. Repair of CRISPR-mediated cleavage of genetic
components encoding for the gene drive may alter either the
activity or the specificity of action with unpredictable con-
sequence in the long term; for example, upon modification of the
targeting sequence of the driving gRNA. Moreover, expression of
anti-CRISPR proteins can be easily restricted to the cell types
where the gene drive is active by using tissue-specific pol II
promoters (e.g., the vasa promoter used here), while gRNA-based
methods generally require ubiquitously active pol III promoters.
The broad spectrum of DNA mimic proteins31,32 expands dra-
matically the application range of this system, which in principle
could be used to counteract any genetic control technology
employing CRISPR–Cas9 tools, without requiring ad hoc engi-
neering for different genetic constructs. This aspect may be par-
ticularly advantageous in the case of synonymous or silent
mutations arising at the driving genetic sequence (naturally or
induced by DNA-cleaving reversal construct) that may prevent
the effect of counteracting systems involving DNA cleavage. In
addition, the generation and selection of resistance to the anti-
drive is reduced compared to DNA-cleaving methods, for which
creation of resistant alleles at the drive target is expected at each
generation as shown for homing gene drive constructs10–13. It
should also be considered that risks related to remobilisation of
the anti-drive protein inhibitor are theoretically reduced com-
pared to other strategies. For instance, in the case a gene drive-
targeting gRNA17 may become genetically linked to a mutated
Cas9 sequence that remains functionally active, but resistant to
further cleavage by the reversal gRNA19. Another aspect to be
considered is that broadly active anti-CRISPR proteins, con-
ferring low fitness costs to the carriers, have the potential to
persist in a population over time, effectively generating a genetic
barrier against newly introduced gene drives or self-limiting
genetic control strategies, which rely on CRISPR–Cas with
overlapping spatiotemporal activity.
As for gene drives, anti-drive technologies such as the one
developed here will also require careful experimental and math-
ematical evaluations before these can be considered as an effective
and field-applicable countermeasure. The effectiveness of this
technology in blocking gene drive spread will ultimately depend
on the relative fitness of drive and anti-drive constructs, as well as
rates and fitness cost associated with genetic resistance against the
drive or anti-drive, although the latter is expected to be reduced
for our protein-based inhibitor compared to DNA-cleaving
approaches. The anti-CRISPR tool described here will also be of
great use to expedite laboratory husbandry of CRISPR–Cas
expressing transgenic lines, including suppressive gene drives,
which usually require continuous backcrossing to wild-type
strains. Finally, this work provides an additional technology for
genetic regulation of CRISPR activity that can be of great use for a
broad range of applications in A. gambiae mosquitoes, as well as
other medically relevant insects, including the model insect
Drosophila melanogaster.
Methods
Anti-CRISPR testing in cell-free reactions. Escherichia coli cell-free reaction
mixture was sourced from Arbor biosciences (Arbor Biosciences, Cat: 507024).
Each 75 µL, 1.25×-concentrated MyTXTL reaction was loaded with the necessary
DNA expression templates and ultimately divided into 5-µL individual reaction
droplets for incubation, expression and fluorescence monitoring, as described in
ref. 31 (Supplementary Fig. 1a). To prevent the degradation of linear DNA
templates, GamS (Arbor Biosciences, Cat: 501024) was added to the 75 µL TXTL
reaction master mix at a final concentration of 2 µM (ref. 33). The anti-CRISPR
protein AcrIIa4 (SPC gb013) and Cas9 sgRNAs were expressed from linear tem-
plate DNA at 1 and 4 nM concentrations, respectively. Cas9 (pCB843) and deGFP
(pCB556) were expressed from plasmid DNA templates at 1 and 0.5 nM con-
centrations, respectively. The reactions were mixed by brief vortexing and collected
using a benchtop centrifuge. Each reaction was split into two aliquots, each of 5 µL,
and loaded into a 96-well V-bottom plate (Corning Costar 3357) and covered with
a cap mat. The 96-well plate with TXTL droplets was loaded into a BioTek Synergy
H1 plate reader at 29 °C without shaking. Fluorescence of TXTL reaction was
measured at Exc. 485 nm, Em. 528 nm every 3 min, for 16 h. Only the fluorescence
from the endpoint of the reaction was reported (Supplementary Fig. 1b).
Plasmid construction. The L. monocytogenes AcrIIA4-coding sequence, synthe-
tised and codon-optimised for A. gambiae (ATUM), was amplified using primers
containing the XhoI cleavage site followed by a NLS at the N-terminus side and the
PacI site after the C-terminus (RG247–RG248; Supplementary Table 3). The
fragment was digested and ligated into a pre-existing vector containing the vasa
promoter and terminator sequences24 flanking the XhoI and PacI sites, the eGFP-
coding sequence under the control of the 3xP3 promoter separated by the ϕC31
attB recombination sequence, resulting in the final plasmid named C77 (Genbank
accession code MZ172909).
Microinjection of embryos and selection of transformed mosquitoes. All
mosquitoes used in this work were reared under standard conditions of 80%
relative humidity and 28 °C. Adult mosquitoes of a previously generated A. gam-
biae attP docking line25 were blood-fed by Hemotek and freshly laid embryos were
aligned for microinjections, as described previously34. The injected solution con-
tained 50 ng/μL of the vasa:AcrIIA4 construct and 400 ng/μL of a helper plasmid
expressing the φC31 integrase under the vasa promoter3. Hatched larvae were
screened for transient expression of the eGFP marker and crossed to wild-type
mosquitoes to obtain transgenic individuals expressing both eGFP and eCFP.
Expression of fluorescent markers was analysed on a Nikon inverted microscope
(Eclipse TE200).
Molecular confirmation of insertion and zygosity assessment. Vasa:A4 and
wild-type mosquitoes were used for genomic DNA extraction, using Qiagen blood
and tissue kit (Qiagen) followed by PCR amplifications at the insertion locus to
confirm the correct integration of the transgene and zygosity of the vasa:A4
released in the cage trial. The ϕC31-mediated integration of the vasa:A4 construct
was confirmed using primers binding the integrated construct and the neigh-
bouring genomic locus, using the RG1044 and RG187 primers (PCR A; Supple-
mentary Fig. 2a, b). The proportion of heterozygous (vasa:A4+/−) and homozygous
(vasa:A4+/+) anti-drive males released in the cage trial was determined, using the
RG1044-5R1 primers binding the transgene and the flanking genomic region (PCR
B) and primers RG1047–RG1044 binding either side of the transgene insertion site
(PCR C). A total of 37 male individuals were assessed for cage 1 and 25 male
individuals for cage 2 (Supplementary Fig. 2a, c, d and Supplementary Table 3).
Mosquito genetic crosses. Vasa:A4 males carrying one copy of the anti-drive
construct (vasa:A4+/−) were crossed to heterozygous females of each gene drive
line (zpg:dsxF+/−, zpg:7280+/− or nos:7280+/−). Larvae carrying one copy of the
drive (RFP positive), one copy of the anti-drive (GFP positive) or both (RFP and
GFP positive) were selected and crossed to wild-type individuals for phenotypic
assays (Supplementary Fig. 3a).
Vasa:A4 males were crossed to virgin females carrying a 3xP3:DsRed marker in
the same locus (mars transgenic line25) to generate individuals carrying either both
transgenes (vasa:A4+/mars+), and therefore homozygous for the disruption of the
genetic locus (GFP and RFP positive) or either transgene in heterozygosity
(GFP positive vasa:A4+/− and RFP positive mars+/−). For each genotype,
transgenic males and females were crossed to wild-type individuals for phenotypic
characterisation (Supplementary Fig. 3b). Transgenic individuals carrying both
transgenes (vasa:A4+/mars+) were also crossed to each other to generate individuals
homozygous either for the vasa:A4 (vasa:A4+/+) or the mars (mars+/+) construct,
as well as siblings carrying one copy of each construct (vasa:A4+/mars+). Males and
females of each genotype were crossed to wild-type for phenotypic characterisation
(Supplementary Fig. 3c).
Phenotypic assays. For each genotype tested, 30 transgenic male or female adults
were crossed to an equal number of wild-type mosquitoes for 5 days, blood-fed and
a minimum of 15 females allowed to lay individually. The entire egg and larval
progeny were counted for each lay (Supplementary Fig. 3). Females that failed to
give progeny and had no evidence of sperm in their spermathecae were excluded
from fertility analysis, but considered for mating analysis (Supplementary Table 1).
To confirm parental zygosity of the vasa:A4 alleles, progenies were also screened
for the presence of WT individuals (negative to fluorescence screening).
Inheritance of gene drive (RFP positive) and anti-drive (GFP positive)
transgenes was measured by screening the entire larval progeny obtained from each
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oviposition. Females that produced less than ten larvae were excluded from the
analysis of transgenic inheritance rates (Fig. 2b).
Statistical differences against selected reference crosses tested in parallel were
assessed using Welch’s unpaired t test, for both larval and egg output averages, and
Fisher’s exact test for the total number of larvae hatched from each cross
(Supplementary Fig. 3).
Discrete-generation (non-overlapping) cage trial. To minimise possible par-
ental bias of Cas9–gRNA deposition and consequent generation of alleles resistant
to the drive, the gene drive individuals released in the cage trial were obtained from
both zpg:dsxF males crossed to wild-type females and zpg:dsxF females crossed to
wild-type males in equal numbers. These were subsequently mixed at L1 stage and
reared in parallel with the offspring of vasa:A4+/− males crossed to vasa:A4+/−
females, and wild-type insects. RFP positive gene drive and GFP positive anti-drive
larvae were screened at L3 stage, and the developing male and female pupae were
sexed and allowed to emerge in individual cages in parallel with wild-type males
and females. Vasa:A4+/+ individuals used for the release were selected based on
higher intensity of the eGFP signal from larval progeny of vasa:A4 heterozygous
parents. Adult mosquitoes were mixed only when all the pupae had emerged.
Two experimental cages were initiated by releasing 150 zpg:dsxF+/− males and
150 zpg:dsxF+/− females (corresponding to a 25% allele frequency at the gene drive
locus) together with 120 anti-drive males enriched for homozygous (~20% allele
frequency of anti-drive alleles), 30 wild-type males and 150 wild-type females
(contributing 30% to the total of ~80% allele frequency of wild-type alleles at the
anti-drive locus and 75% for the drive locus). In parallel, two control cages were
initiated by releasing an equal number of gene drive mosquitoes (150 zpg:dsxF+/−
males and 150 zpg:dsxF+/− females) with 150 wild-type males and 150 wild-type
females (corresponding to 25% allele frequency of the gene drive).
Each generation, mosquitoes were left to mate for 5 days before they were
blood-fed on anaesthetised mice. Two days later, egg bowls filled with water and
lined with filter paper were added in the cages to allow for overnight oviposition.
The following day, eggs laid in the egg bowl were dispersed using gentle water
spraying to homogenise the population, and 650 eggs were randomly selected to
seed the next generation. The remaining eggs were photographed and counted
using JMicroVision V1.27 to obtain the overall egg output from each cage (Fig. 3b
and Source data file). Larvae hatching from the 650 eggs were counted and reared
at a density of 200 per tray (in ∼0.5 litre of water). L2/L3 larvae were screened for
the presence of the RFP and GFP marker to measure gene drive and anti-drive
genotype frequencies (Fig. 3a and Source data file). All the pupae obtained from the
650 eggs were used to seed the following generation.
Animal husbandry. Mosquitoes in the cage trials were fed using anaesthetised
2–6 month old female mice (CD1 strain). CD1 mice were kept in social-housing caged
units with 12/12 light–dark cycles, 45–65% relative humidity and at temperature of
20–24 °C. All animal work was conducted according to UK Home Office Regulations
and approved under Home Office License PPL 70/8914 by the AWERB at Imperial
College London.
Amplicon sequencing analysis. Adult mosquitoes were collected at G1, G5, G10
and G15 from each of the four cages after obtaining the respective progenies
(Fig. 3). DNA extraction from pooled individuals, PCR amplification and amplicon
sequencing were performed for each of the 14 samples as previously
described2 using the 4050-Illumina-F and 4050-Illumina-R primers. Raw ampli-
con sequencing data were deposited in the EBI-ENA database (accession code
PRJEB44729). The CRISPResso v1.0.8 software35 was used to analyse the frequency
of wild-type and mutated sequences at the zpg:dsxF gene drive target as previously
described2, accounting for all indels and substitutions present at the target
sequence and/or any of the two invariable nucleotides of the corresponding PAM
sequence (-GG). Exogenous contaminant alleles were removed bioinformatically2
(Supplementary Fig. 4a).
Modelling. Discrete-generation recursion equations were used for genotype fre-
quencies, with males and females treated separately as in refs. 2,11,25. Here, we
model two loci: the gene drive locus, where we consider three alleles,W (wild-type),
D (drive) and R (non-functional nuclease-resistant), and the anti-drive site with
two alleles W (wild-type) and A (anti-drive). FijjklðtÞ and Mijjkl tð Þ denote the
genotype frequency of females (or males) in the total population, where the first set
of indices denotes alleles at the target locus ij ¼ fWW;WD;WR;DD;DR;RRg, and
the second set denotes the anti-drive locus, kl ¼ fWW;WA;AAg. For simplicity,
we assume full recombination and no linkage between the loci. There are 18 female
genotypes and 18 male genotypes (see list in Supplementary Table 2); 6 types of
eggs in proportions EWjW ; EWjA;EDjW , EDjA , ERjW , ERjA, where the first index refers
to the target site allele and the second to the anti-drive; and similarly 6 types of
sperm, SWjW ; SWjA; SDjW ; SDjA , SRjW , SRjA.
Homing of the gene drive is assumed to occur only when the anti-drive is not
present. Adults of genotype WDjWW (i.e., with no anti-drive) produce gametes at
meiosis in the ratioWjW : DjW : RjW as follows: ð1 df Þð1 uf Þ : df : ð1 df Þuf




: dm : 1 dm
 
um in males. Here, df and dm are the
rates of transmission of the driver allele in the two sexes, and uf and um are the
fractions of non-drive gametes at the target site that are repaired by meiotic end-
joining and are non-functional and resistant to the drive (R). If the anti-drive is
present (WD|WA and WD|AA), drive inheritance is Mendelian. In all other
genotypes, inheritance at the target site is also Mendelian. In the deterministic model,
fitness effects are manifested as differences in the relative ability of female or male
genotypes to participate in mating and reproduction. We let wijjkl ≤ 1 represent the
fitness of genotype ijjkl relative to wWWjWW ¼ 1 for the wild-type homozygote (see
“overall fitness” in Supplementary Table 2). We assume the dsx-target gene is needed
for female fertility, thus females with DD, DR and RR at the gene drive locus are
sterile.
We firstly consider the gamete contributions from each genotype. The
proportions EmjnðtÞ with allele m ¼ fW;D;Rg at the gene drive locus, and n ¼
fW;Ag at the anti-drive locus in eggs produced by females participating in
reproduction are given in terms of the female genotype frequencies Fijjkl tð Þ:

















where i and j are each summed such that {1, 2, 3} corresponds to {W, D, R} and k
and l such that {1, 2} corresponds to {W, A}. The coefficients cm;nijjkl correspond to
the proportion of the gametes from female individuals of type (ijjkl) that carry
alleles (mjn). For example, assuming no linkage, for a female of genotype WD|WA,
the coefficient for alleles of type mjn ¼ WjW;WjA;DjW and DjA is =¼, since
inheritance of the drive is Mendelian due to the presence of anti-drive in that
genotype, and is zero for alleles of type RjW and RjA, since it is assumed that no
end-joining resistance is generated with anti-drive present. An analogous
expression is used for sperm:

















To model cage experiments, the initial frequency of heterozygote drive females
and males is FWDjWW ¼ MWDjWW ¼ 0:25, of anti-drive males MWWjAA ¼ 0:2, and
of wild-type female and males FWWjWW ¼ 0:25 and MWW;WW ¼ 0:05. For release
of gene drive only, MWW;WW ¼ MWD;WW ¼ 1=4 and FWW;WW ¼ FWD;WW ¼ 1=4:
Assuming random mating, we obtain the following recursion equations for the
female genotype frequencies in the next generation ðt þ 1Þ:









Eijk tð ÞSjjk tð Þ þ Ejjk tð ÞSijk tð Þ

þ Eijl tð ÞSjjl tð Þ þ Ejjl tð ÞSijl tð Þ

where δij is the Kronecker delta. The factors ð1
δij
2 Þ; ð1 δkl2 Þ account for the factor
of 1/2 for homozygosity at the drive target site (for ij ¼ {WW, DD, RR}) and at the
anti-drive site (for {WW;AA}). Similar equations may be written for the male
genotype frequencies Mijjklðt þ 1Þ.
In the deterministic model, the load on the population incorporates reductions
in female and male fertility and at time t is defined as:
LðtÞ ¼ 1 2FðtÞwf ðtÞwmðtÞ
where wf tð Þ ¼ ∑18k¼1 wkFk tð Þ=∑18k¼1 Fk tð Þ is the average female fitness and
wm tð Þ ¼ ∑18k¼1 wkMk tð Þ=∑18k¼1 Mk tð Þ is the average male fitness (here, k is summing
over the 18 genotypes). F tð Þ ¼ ∑18k¼1 Fk tð Þ is the proportion of females in the
population (¼ 1=2 except for the zeroth generation). The load is zero when only
wild-types are present.
In the stochastic version of the model, as in refs. 2,5, probabilities of mating, egg
production, hatching and emergence from pupae are estimated from experiments
(Supplementary Table 2), and random numbers for these events are taken from the
appropriate multinomial distributions. To model the cage experiments, 150 female
and 30 male wild-type adults along with 120 male drive homozygotes (WD|AA),
and 150 each female and male heterozygous for the drive (WD|WW) are initially
present (600 individuals in total). For experiments with gene drive only and no
anti-drive, there are 150 each of female and male WD|WW gene drive
heterozygotes and 150 of wild-type adults. Females may fail to mate, or mate once
in their life, with a male of a given genotype according to its frequency in the male
population times its mating fitness (relative to wild-type), chosen randomly with
replacement such that males may mate multiple times. The number of eggs from
each mated female is multiplied by the egg production of the male relative to wild-
type. To start the next generation, 650 eggs are randomly selected, and their
hatching probability depends on the product of larval hatching values from the
mother and father. The probability of subsequent survival to adulthood is assumed
to be equal across genotypes. Assuming very large population sizes gives results for
the genotype frequencies that are indistinguishable from the deterministic model.
For the deterministic egg count, we use the large population limit of the
stochastic model.
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Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Raw-sequencing data were deposited in the EBI-ENA database under accession code
PRJEB44729. The C77 plasmid sequence was deposited in the NCBI database under
accession code MZ172909. Source data are provided with this paper.
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